✦ LIBER ✦

Efficacy, safety and dose-response relationship of teneligliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus

✍ Scribed by Kadowaki, T.; Kondo, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of the dipeptidyl pe

✍ I. Raz; M. Hanefeld; L. Xu; C. Caria; D. Williams-Herman; H. Khatami; Sitaglipti 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 160 KB

Long-term safety, tolerability, and effi

✍ Masato Odawara; Takashi Kadowaki; Naoko Tajima; Mikio Nishii; Tadaaki Taniguchi; 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 377 KB

Efficacy and Safety of Dipeptidyl Peptid

✍ Park, H.; Park, C.; Kim, Y.; Rascati, K. L. 📂 Article 📅 2012 🏛 Harvey Whitney Books Company 🌐 English ⚖ 558 KB

Safety and efficacy of teneligliptin: a

✍ Otsuki, Hideo; Kosaka, Takeo; Nakamura, Kenzo; Shimomura, Fumihiko; Kuwahara, Yo 📂 Article 📅 2013 🏛 Springer Netherlands 🌐 English ⚖ 251 KB

The efficacy and safety of the dipeptidy

✍ Robert Frederich, Robert McNeill, Niklas Berglind, Douglas Fleming, Roland Chen 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 239 KB

Contributing factors related to efficacy

✍ Takashi Nomiyama; Yuko Akehi; Hiromasa Takenoshita; Ryoko Nagaishi; Yuichi Teraw 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 159 KB